Roles of group I metabotropic glutamate receptors under physiological conditions and in neurodegeneration

Wiley Interdisciplinary Reviews: Membrane Transport and Signaling

Volumn 1, Issue 4, 2012, Pages 523-532

  Baudry, Michel ^a   Greget, Renaud ^b   Pernot, Fabien ^b   Bouteiller, Jean Marie ^c   Xiaoning, Bi ^d  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b Rhenovia Pharma   (France)

^c University of Southern California ^*  (United States)

^d Western University of Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR 4; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR 6; METABOTROPIC RECEPTOR 8; NEUROPROTECTIVE AGENT; TAT METABOTROPIC RECEPTOR 1 PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; DEGENERATIVE DISEASE; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INTRACELLULAR SIGNALING; MENTAL DISEASE; MOLECULAR PATHOLOGY; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; SYNAPTIC TRANSMISSION;

EID: 84873803980     PISSN: 2190460X     EISSN: 21904618     Source Type: Journal    
DOI: 10.1002/wmts.51     Document Type: Article

References (68)

1. Bockaert J, Pin JP. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J 1999, 18:1723-1729.
2. Petralia RS, Wang YX, Singh S, Wu C, Shi L, Wei J, Wenthold RJ. A monoclonal antibody shows discrete cellular and subcellular localizations of mGluR1 α metabotropic glutamate receptors. J Chem Neuroanat 1997, 13:77-93.
3. Baude A, Nusser Z, Roberts JD, Mulvihill E, McIlhinney RA, Somogyi P. The metabotropic glutamate receptor (mGluR1 α) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction. Neuron 1993, 11:771-787.
4. Martin LJ, Blackstone CD, Huganir RL, Price DL. Cellular localization of a metabotropic glutamate receptor in rat brain. Neuron 1992, 9:259-270.
5. Shigemoto R, Nakanishi S, Mizuno N. Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: an in situ hybridization study in adult and developing rat. J Comp Neurol 1992, 322:121-135.
6. Bockaert J, Perroy J, Becamel C, Marin P, Fagni L. GPCR interacting proteins (GIPs) in the nervous system: roles in physiology and pathologies. Annu Rev Pharmacol Toxicol 2010, 50:89-109.
7. Das SS, Banker GA. The role of protein interaction motifs in regulating the polarity and clustering of the metabotropic glutamate receptor mGluR1a. J Neurosci 2006, 26:8115-8125.
8. Tu JC, Xiao B, Naisbitt S, Yuan JP, Petralia RS, Brakeman P, Aakala VK, Lanahan AA, Sheng M, Worley PF. Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron 1999, 23:583-592.
9. Rong R, Ahn JY, Huang H, Nagata E, Kalman D, Kapp JA, Tu J, Worley PF, Snyder SH, Ye K. PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis. Nat Neurosci 2003, 6:1153-1161.
10. Thandi S, Blank JL, Challiss RA. Group-I metabotropic glutamate receptors, mGlu1a and mGlu5a, couple to extracellular signal-regulated kinase (ERK) activation via distinct, but overlapping, signalling pathways. J Neurochem 2002, 83:1139-1153.
11. Page G, Khidir FA, Pain S, Barrier L, Fauconneau B, Guillard O, Piriou A, Hugon J. Group I metabotropic glutamate receptors activate the p70S6 kinase via both mammalian target of rapamycin (mTOR) and extracellular signal-regulated kinase (ERK 1/2) signaling pathways in rat striatal and hippocampal synaptoneurosomes. Neurochem Int 2006, 49:413-421.
12. Tateyama M, Kubo Y. Dual signaling is differentially activated by different active states of the metabotropic glutamate receptor 1α. Proc Natl Acad Sci U S A 2006, 103:1124-1128.
13. Batchelor AM, Garthwaite J. Frequency detection and temporally dispersed synaptic signal association through a metabotropic glutamate receptor pathway. Nature 1997, 385:74-77.
14. Rodriguez-Moreno A, Sistiaga A, Lerma J, Sanchez-Prieto J. Switch from facilitation to inhibition of excitatory synaptic transmission by group I mGluR desensitization. Neuron 1998, 21:1477-1486.
15. Lesage A, Steckler T. Metabotropic glutamate mGlu1 receptor stimulation and blockade: therapeutic opportunities in psychiatric illness. Eur J Pharmacol 2010, 639:2-16.
16. Nicoletti F, Bockaert J, Collingridge GL, Conn PJ, Ferraguti F, Schoepp DD, Woblewski JT, Pin JP. Metabotropic glutamate receptors: from the workbench to the bedside. Neuropharmacology 2011, 60: 1017-1041.
17. Niswender CM, Conn PJ. Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol 2010, 50:295-322.
18. Greget R, Pernot F, Bouteiller JM, Ghaderi V, Allam S, Keller AF, Ambert N, Legendre A, Sarmiss M, Haeberle O, et al. Simulation of postsynaptic glutamate receptors reveals critical features of glutamatergic transmission. PLoS ONE 2011, 6:e28380.
19. Zheng K, Scimemi A, Rusakov DA. Receptor actions of synaptically released glutamate: the role of transporters on the scale from nanometers to microns. Biophys J 2008, 95:4584-4596.
20. Scanziani M. Competing on the edge. Trends Neurosci 2002, 25:282-283.
21. Anwyl R. Metabotropic glutamate receptor-dependent long-term potentiation. Neuropharmacology 2009, 56: 735-740.
22. Nevian T, Sakmann B. Spine Ca2+ signaling in spike-timing-dependent plasticity. J Neurosci 2006, 26: 11001-11013.
23. Nishiyama M, Hong K, Mikoshiba K, Poo MM, Kato K. Calcium stores regulate the polarity and input specificity of synaptic modification. Nature 2000, 408: 584-588.
24. Holbro N, Grunditz A, Oertner TG. Differential distribution of endoplasmic reticulum controls metabotropic signaling and plasticity at hippocampal synapses. Proc Natl Acad Sci U S A 2009, 106:15055-15060.
25. Le Duigou C, Kullmann DM. Group I mGluR agonist-evoked long-term potentiation in hippocampal oriens interneurons. J Neurosci 2011, 31:5777-5781.
26. Gladding CM, Fitzjohn SM, Molnar E. Metabotropic glutamate receptor-mediated long-term depression: molecular mechanisms. Pharmacol Rev 2009, 61: 395-412.
27. Hu JH, Park JM, Park S, Xiao B, Dehoff MH, Kim S, Hayashi T, Schwarz MK, Huanir RL, Seeburg PH, et al. Homeostatic scaling requires group I mGluR activation mediated by Homer1a. Neuron 2010, 68:1128-1142.
28. Luscher C, Huber KM. Group 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and disease. Neuron 2010, 65: 445-459.
29. Casimiro TM, Sossa KG, Uzunova G, Beattie JB, Marsden KC, Carroll RC. mGluR and NMDAR activation internalize distinct populations of AMPARs. Mol Cell Neurosci 2011, 48:161-170.
30. Nadif Kasri N, Nakano-Kobayashi A, Van Aelst L. Rapid synthesis of the X-linked mental retardation protein OPHN1 mediates mGluR-dependent LTD through interaction with the endocytic machinery. Neuron 2011, 72:300-315.
31. Bellone C, Luscher C, Mameli M. Mechanisms of synaptic depression triggered by metabotropic glutamate receptors. Cell Mol Life Sci 2008, 65:2913-2923.
32. Tempia F, Miniaci MC, Anchisi D, Strata P. Postsynaptic current mediated by metabotropic glutamate receptors in cerebellar Purkinje cells. J Neurophysiol 1998, 80:520-528.
33. Brasnjo G, Otis TS. Neuronal glutamate transporters control activation of postsynaptic metabotropic glutamate receptors and influence cerebellar long-term depression. Neuron 2001, 31:607-616.
34. Marcaggi P, Hirji N, Attwell D. Release of L-aspartate by reversal of glutamate transporters. Neuropharmacology 2005, 49:843-849.
35. Reichelt W, Knopfel T. Glutamate uptake controls expression of a slow postsynaptic current mediated by mGluRs in cerebellar Purkinje cells. J Neurophysiol 2002, 87:1974-1980.
36. Fan W, Ster J, Gerber U. Activation conditions for the induction of metabotropic glutamate receptor-dependent long-term depression in hippocampal CA1 pyramidal cells. J Neurosci 2010, 30:1471-1475.
37. Vincent AM, Maiese K. The metabotropic glutamate system promotes neuronal survival through distinct pathways of programmed cell death. Exp Neurol 2000, 166:65-82.
38. Zhu P, DeCoster MA, Bazan NG. Interplay among platelet-activating factor, oxidative stress, and group I metabotropic glutamate receptors modulates neuronal survival. J Neurosci Res 2004, 77:525-531.
39. Sagara Y, Schubert D. The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress. J Neurosci 1998, 18:6662-6671.
40. Blaabjerg M, Fang L, Zimmer J, Baskys A. Neuroprotection against NMDA excitotoxicity by group I metabotropic glutamate receptors is associated with reduction of NMDA stimulated currents. Exp Neurol 2003, 183:573-580.
41. Chong ZZ, Li F, Maiese K. Group I metabotropic receptor neuroprotection requires Akt and its substrates that govern FOXO3a, Bim, and β-catenin during oxidative stress. Curr Neurovasc Res 2006, 3:107-117.
42. Hou L, Klann E. Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J Neurosci 2004, 24:6352-6361.
43. Pellegrini-Giampietro DE. The distinct role of mGlu1 receptors in post-ischemic neuronal death. Trends Pharmacol Sci 2003, 24:461-470.
44. Xu W, Wong TP, Chery N, Gaertner T, Wang YT, Baudry M. Calpain-mediated mGluR1α truncation: a key step in excitotoxicity. Neuron 2007, 53:399-412.
45. Brooks H, Lebleu B, Vives E. Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev 2005, 57:559-577.
46. Zhou M, Xu W, Liao G, Bi X, Baudry M. Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1α truncation. Exp Neurol 2009, 218:75-82.
47. Bright R, Raval AP, Dembner JM, Perez-Pinzon MA, Steinberg GK, Yenari MA, Mochly-Rosen D. Protein kinase C δ mediates cerebral reperfusion injury in vivo. J Neurosci 2004, 24:6880-6888.
48. Bertaso F, Zhang C, Scheschonka A, et al. PICK1 uncoupling from mGluR7a causes absence-like seizures. Nat Neurosci 2008, 11:940-948.
49. Guan QH, Pei DS, Zong YY, Xu TL, Zhang GY. Neuroprotection against ischemic brain injury by a small peptide inhibitor of c-Jun N-terminal kinase (JNK) via nuclear and non-nuclear pathways. Neuroscience 2006, 139:609-627.
50. Xie Y, Massa SM, Ensslen-Craig SE, Major DL, Yang T, Tisi MA, Derevyanny VD, Runge WO, Mehta BP, Moore LA, et al. Protein-tyrosine phosphatase (PTP) wedge domain peptides: a novel approach for inhibition of PTP function and augmentation of protein-tyrosine kinase function. J Biol Chem 2006, 281: 16482-16492.
51. McConnell KW, Muenzer JT, Chang KC, Davis CG, McDunn JE, Coopersmith CM, Hilliard CA, Hotchkiss RS, Grigsby PW, Hunt CR. Anti-apoptotic peptides protect against radiation-induced cell death. Biochem Biophys Res Commun 2007, 355:501-507.
52. Faden AI, Ivanova SA, Yakovlev AG, Mukhin AG. Neuroprotective effects of group III mGluR in traumatic neuronal injury. J Neurotrauma 1997, 14:885-895.
53. Maj M, Bruno V, Dragic Z, Yamamoto R, Batlaglia G, Inderbitzin W, Stoehr N, Stein T, Gasparini F, Vranesic I, et al. (-)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection. Neuropharmacology 2003, 45:895-906.
54. Berent-Spillson A, Russell JW. Metabotropic glutamate receptor 3 protects neurons from glucose-induced oxidative injury by increasing intracellular glutathione concentration. J Neurochem 2007, 101:342-354.
55. Vernon AC, Croucher MJ, Dexter DT. Additive neuroprotection by metabotropic glutamate receptor subtype-selective ligands in a rat Parkinson's model. Neuroreport 2008, 19:475-478.
56. Vernon AC, Zbarsky V, Datla KP, Dexter DT, Croucher MJ. Selective activation of group III metabotropic glutamate receptors by L-(+)-2-amino-4-phosphonobutryic acid protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo. J Pharmacol Exp Ther 2007, 320:397-409.
57. Zhou F, Yao HH, Wu JY, Yang YJ, Ding JH, Zhang J, Hu G. Activation of Group II/III metabotropic glutamate receptors attenuates LPS-induced astroglial neurotoxicity via promoting glutamate uptake. J Neurosci Res 2006, 84:268-277.
58. Hikichi H, Nishino M, Fukushima M, Satow A, Maehara S, Kawamoto H, Ohta H. Pharmacological effects of metabotropic glutamate receptor ligands on prepulse inhibition in DBA/2J mice. Eur J Pharmacol 2010, 639:99-105.
59. Braff DL, Grillon C, Geyer MA. Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 1992, 49:206-215.
60. Harvey BH, Shahid M. Metabotropic and ionotropic glutamate receptors as neurobiological targets in anxiety and stress-related disorders: Focus on pharmacology and preclinical translational models. Pharmacol Biochem Behav 2012, 100:775-800.
61. Tokita K, Yamaji T, Hashimoto K. Roles of glutamate signaling in preclinical and/or mechanistic models of depression. Pharmacol Biochem Behav 2012, 100: 688-704.
62. Krueger DD, Bear MF. Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu Rev Med 2011, 62:411-429.
63. Yamamoto N, Soghomonian JJ. Metabotropic glutamate mGluR5 receptor blockade opposes abnormal involuntary movements and the increases in glutamic acid decarboxylase mRNA levels induced by l-DOPA in striatal neurons of 6-hydroxydopamine-lesioned rats. Neuroscience 2009, 163:1171-1180.
64. Johnston TH, Fox SH, McIldowie MJ, Piggott MJ, Brotchie JM. Reduction of L-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1, 3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. J Pharmacol Exp Ther 2010, 333: 865-873.
65. Rylander D, Iderberg H, Li Q, Dekundy A, Zhang J, Li H, Baishen R, Damysz W, Bezard E, Cenci MA. A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys. Neurobiol Dis 2010, 39:352-361.
66. Masu M, Tanabe Y, Tsuchida K, Shigemoto R, Nakanishi S. Sequence and expression of a metabotropic glutamate receptor. Nature 1991, 349:760-765.
67. Giovanni M, Hibiki K, eds. Neurodegeneration: Methods and Protocols. Series "Methods in Molecular Biology", vol. 793. New York: Springer; 2011.
68. Beal F, Lang AE, Ludolph AC, eds. Neurodegenerative Diseases: Neurobiology, Pathogenesis and Therapeutics. Cambridge: Cambridge University Press; 2005.